Resultats de la cerca - Giuseppe Procopio

Refinar resultats
  1. 1
    Costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: bevacizumab in combination with interferon-α2a compared with sunitinib

    Costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: bevacizumab in combination with interferon-α2a compared with sunitinib per G. Mickisch, M. Gore, Bernard Escudier, Giuseppe Procopio, Stefan Walzer, Mark Nuijten

    Publicat 2009
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up per Chris Parker, Elena Castro, Karim Fizazi, Axel Heidenreich, Piet Ost, Giuseppe Procopio, Bertrand Tombal, Silke Gillessen

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Incidence and relative risk of hepatic toxicity in patients treated with anti-angiogenic tyrosine kinase inhibitors for malignancy

    Incidence and relative risk of hepatic toxicity in patients treated with anti-angiogenic tyrosine kinase inhibitors for malignancy per Roberto Iacovelli, Antonella Palazzo, Giuseppe Procopio, Matteo Santoni, Patrizia Trenta, Angelina De Benedetto, Silvia Mezi, Enrico Cortesi

    Publicat 2013
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  4. 4
    ESMO Clinical Practice Guideline update on the use of immunotherapy in early stage and advanced renal cell carcinoma

    ESMO Clinical Practice Guideline update on the use of immunotherapy in early stage and advanced renal cell carcinoma per Thomas Powles, Laurence Albigès, Axel Bex, Viktor Grünwald, Camillo Porta, Giuseppe Procopio, Manuela Schmidinger, Cristina Suárez, Guillermo de Velasco

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Sorafenib with interleukin-2 vs sorafenib alone in metastatic renal cell carcinoma: the ROSORC trial

    Sorafenib with interleukin-2 vs sorafenib alone in metastatic renal cell carcinoma: the ROSORC trial per Giuseppe Procopio, Elena Verzoni, Sergio Bracarda, Serafino Ricci, Cosimo Sacco, Laura Ridolfi, Camillo Porta, Rosalba Miceli, Nicoletta Zilembo, Emilio Bajetta

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    5-fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumors

    5-fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumors per Emilio Bajetta, Lorenza Rimassa, Carlo Carnaghi, Ettore Seregni, Leonardo Ferrari, Maria Di Bartolomeo, Enrico Regalia, Antonio Cassata, Giuseppe Procopio, Luigi Mariani

    Publicat 1998
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Sorafenib tolerability in elderly patients with advanced renal cell carcinoma: results from a large pooled analysis

    Sorafenib tolerability in elderly patients with advanced renal cell carcinoma: results from a large pooled analysis per Giuseppe Procopio, Joaquim Bellmunt, Janice P. Dutcher, Sergio Bracarda, Jennifer J. Knox, Andreas Brueckner, István Molnár, Bernard Escudier, Thomas E. Hutson

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Predictive Biomarkers of Response to Immunotherapy in Metastatic Renal Cell Cancer

    Predictive Biomarkers of Response to Immunotherapy in Metastatic Renal Cell Cancer per Alessandra Raimondi, Pierangela Sepe, Emma Zattarin, Alessia Mennitto, Marco Stellato, Mélanie Claps, Valentina Guadalupi, Elena Verzoni, Filippo de Braud, Giuseppe Procopio

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  9. 9
    Safety and Efficacy of Two Different Doses of Capecitabine in the Treatment of Advanced Breast Cancer in Older Women

    Safety and Efficacy of Two Different Doses of Capecitabine in the Treatment of Advanced Breast Cancer in Older Women per Emilio Bajetta, Giuseppe Procopio, Luigi Celio, Luca Gattinoni, S. Della Torre, Luigi Mariani, Laura Catena, Riccardo Ricotta, Raffaella Longarini, Nicoletta Zilembo, Roberto Buzzoni

    Publicat 2005
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Treatment-related fatigue with sorafenib, sunitinib and pazopanib in patients with advanced solid tumors: An up-to-date review and meta-analysis of clinical trials

    Treatment-related fatigue with sorafenib, sunitinib and pazopanib in patients with advanced solid tumors: An up-to-date review and meta-analysis of clinical trials per Matteo Santoni, Alessandro Conti, Francesco Massari, Giorgio Arnaldi, Roberto Iacovelli, Mimma Rizzo, Ugo De Giorgi, Laura Trementino, Giuseppe Procopio, Giampaolo Tortora, Stefano Cascinu

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  11. 11
    Is the new WHO classification of neuroendocrine tumours useful for selecting an appropriate treatment?

    Is the new WHO classification of neuroendocrine tumours useful for selecting an appropriate treatment? per Emilio Bajetta, Laura Catena, Giuseppe Procopio, E. Bichisao, L. Ferrari, S. Della Torre, Sara De Dosso, Silvia Iacobelli, Roberto Buzzoni, Luigi Mariani, J Rosai

    Publicat 2005
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Analysis of Single Circulating Tumor Cells in Renal Cell Carcinoma Reveals Phenotypic Heterogeneity and Genomic Alterations Related to Progression

    Analysis of Single Circulating Tumor Cells in Renal Cell Carcinoma Reveals Phenotypic Heterogeneity and Genomic Alterations Related to Progression per Vera Cappelletti, Elena Verzoni, Raffaele Ratta, Marta Vismara, Marco Silvestri, Rosanna Montone, Patrizia Miodini, Carolina Reduzzi, Mélanie Claps, Pierangela Sepe, Maria Grazia Daidone, Giuseppe Procopio

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    Angiogenesis and Immunity in Renal Carcinoma: Can We Turn an Unhappy Relationship into a Happy Marriage?

    Angiogenesis and Immunity in Renal Carcinoma: Can We Turn an Unhappy Relationship into a Happy Marriage? per Alessia Mennitto, Veronica Huber, Raffaele Ratta, Pierangela Sepe, Filippo de Braud, Giuseppe Procopio, Valentina Guadalupi, Mélanie Claps, Marco Stellato, Elena Daveri, Licia Rivoltini, Elena Verzoni

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  14. 14
    Cabozantinib as First-line Treatment in Patients With Metastatic Collecting Duct Renal Cell Carcinoma

    Cabozantinib as First-line Treatment in Patients With Metastatic Collecting Duct Renal Cell Carcinoma per Giuseppe Procopio, Pierangela Sepe, Mélanie Claps, Sebastiano Buti, Maurizio Colecchia, Patrizia Giannatempo, Valentina Guadalupi, Luigi Mariani, Luca Lalli, Giovanni Fucá, Filippo de Braud, Elena Verzoni

    Publicat 2022
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    nmCRPC, a look in the continuous care of prostate cancer patients: state of art and future perspectives

    nmCRPC, a look in the continuous care of prostate cancer patients: state of art and future perspectives per Alfredo Berruti, Sergio Bracarda, Orazio Caffo, Enrico Cortesi, Rolando Maria D’Angelillo, Marzia Del Re, Gaetano Facchini, Giovanni Pappagallo, Giuseppe Procopio, Roberto Sabbatini, Daniele Santini

    Publicat 2023
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  16. 16
    Efficacy of a chemotherapy combination for the treatment of metastatic neuroendocrine tumours

    Efficacy of a chemotherapy combination for the treatment of metastatic neuroendocrine tumours per Emilio Bajetta, L. Ferrari, Giuseppe Procopio, Laura Catena, Erminia Ferrario, Antonia Martinetti, Maria Di Bartolomeo, Roberto Buzzoni, Luigi Celio, Milena Vitali, Elena Beretta, Ettore Seregni, Emilio Bombardieri

    Publicat 2002
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Final results of the European Advanced Renal Cell Carcinoma Sorafenib (EU-ARCCS) expanded-access study: a large open-label study in diverse community settings

    Final results of the European Advanced Renal Cell Carcinoma Sorafenib (EU-ARCCS) expanded-access study: a large open-label study in diverse community settings per Jochaim Beck, Giuseppe Procopio, Emilio Bajetta, Ulrich Keilholz, Sylvie Négrier, Cezary Szczylik, Carsten Bokemeyer, Sergio Bracarda, D. J. Richel, Michael Staehler, U.P. Strauss, Sabine Mersmann, K. Burock, Bernard Escudier

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Treatment Patterns in Patients (Pts) with Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Previously Treated with Docetaxel (Doc)-Based Chemotherapy (Ctx): Proxima

    Treatment Patterns in Patients (Pts) with Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Previously Treated with Docetaxel (Doc)-Based Chemotherapy (Ctx): Proxima per Hideyuki Akaza, Giuseppe Procopio, Choosak Pripatnanont, Gaetano Facchini, S. Fava, Duncan Wheatley, K.C. Leung, Mohammad Butt, A. Silva, Lucía Castillo, George Fountzilas, Simon Hitier, Evelyne Ecstein-Fraïsse, Samira Bensfia, Mustafa Özgüroğlu

    Publicat 2014
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    International multicenter real-world REGistry for patients with metastatic renAL cell carcinoma – Meet-URO 33 study (REGAL study)

    International multicenter real-world REGistry for patients with metastatic renAL cell carcinoma – Meet-URO 33 study (REGAL study) per Sara Elena Rebuzzi, Giuseppe Fornarini, Alessio Signori, Sebastiano Buti, Giuseppe Procopio, Ugo De Giorgi, Sandro Pignata, Emanuele Naglieri, Marco Maruzzo, Giuseppe Luigi Banna, Pasquale Rescigno, Carlo Messina, Alvise Mattana, Umberto Basso, Davide Bimbatti

    Publicat 2024
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Clinical impact of volume of disease and time of metastatic disease presentation on patients receiving enzalutamide or abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancer

    Clinical impact of volume of disease and time of metastatic disease presentation on patients receiving enzalutamide or abiraterone acetate plus prednisone as first-line therapy for... per Pier Vitale Nuzzo, Filippo Pederzoli, Calogero Saieva, Elisa Zanardi, Giuseppe Fotia, Andrea Malgeri, Sabrina Rossetti, Loana Valenca Bueno, Livia Andrade, Anna Patrikidou, Ricardo Pereira Mestre, Mikol Modesti, Sandro Pignata, Giuseppe Procopio, Giuseppe Fornarini, Ugo De Giorgi, Antonio Russo, Edoardo Francini

    Publicat 2023
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: